Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 154

1.

From oxycodone to heroin: two cases of transitioning opioid use in young Australians.

Dertadian GC, Maher L.

Drug Alcohol Rev. 2014 Jan;33(1):102-4. doi: 10.1111/dar.12093. Epub 2013 Nov 21.

PMID:
24256365
2.

"Every 'never' I ever said came true": transitions from opioid pills to heroin injecting.

Mars SG, Bourgois P, Karandinos G, Montero F, Ciccarone D.

Int J Drug Policy. 2014 Mar;25(2):257-66. doi: 10.1016/j.drugpo.2013.10.004. Epub 2013 Oct 19.

3.

Jurisdictional differences in opioid use, other licit and illicit drug use, and harms associated with substance use among people who tamper with pharmaceutical opioids.

Peacock A, Bruno R, Cama E, Kihas I, Larance B, Lintzeris N, Hordern A, White N, Ali R, Degenhardt L.

Drug Alcohol Rev. 2015 Nov;34(6):611-22. doi: 10.1111/dar.12279. Epub 2015 Jun 18.

PMID:
26084592
4.

Initiation into prescription opioid misuse amongst young injection drug users.

Lankenau SE, Teti M, Silva K, Jackson Bloom J, Harocopos A, Treese M.

Int J Drug Policy. 2012 Jan;23(1):37-44. doi: 10.1016/j.drugpo.2011.05.014. Epub 2011 Jun 20.

5.

Oxycodone abuse in New York City: characteristics of intravenous and intranasal users.

Jones JD, Vosburg SK, Manubay JM, Comer SD.

Am J Addict. 2011 May-Jun;20(3):190-5. doi: 10.1111/j.1521-0391.2011.00120.x. Epub 2011 Mar 8.

6.

Illicit use of opioids: is OxyContin a "gateway drug"?

Grau LE, Dasgupta N, Harvey AP, Irwin K, Givens A, Kinzly ML, Heimer R.

Am J Addict. 2007 May-Jun;16(3):166-73.

PMID:
17612819
7.

Pharmaceutical opioid analgesic and heroin dependence: how do treatment-seeking clients differ in Australia?

Nielsen S, Bruno R, Lintzeris N, Fischer J, Carruthers S, Stoové M.

Drug Alcohol Rev. 2011 May;30(3):291-9. doi: 10.1111/j.1465-3362.2011.00302.x.

PMID:
21545560
8.

Prescription of opioid analgesics and related harms in Australia.

Roxburgh A, Bruno R, Larance B, Burns L.

Med J Aust. 2011 Sep 5;195(5):280-4.

PMID:
21895598
9.

'South Asian cocktail'--the concurrent use of opioids, benzodiazepines and antihistamines among injecting drug users in Nepal and associations with HIV risk behaviour.

Ojha SP, Sigdel S, Meyer-Thompson HG, Oechsler H, Verthein U.

Harm Reduct J. 2014 May 23;11:17. doi: 10.1186/1477-7517-11-17.

10.

Changes in non-opioid substitution treatment episodes for pharmaceutical opioids and heroin from 2002 to 2011.

Nielsen S, Roxburgh A, Bruno R, Lintzeris N, Jefferson A, Degenhardt L.

Drug Alcohol Depend. 2015 Apr 1;149:212-9. doi: 10.1016/j.drugalcdep.2015.02.004. Epub 2015 Feb 12.

PMID:
25707708
11.

Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia.

Degenhardt L, Gilmour S, Shand F, Bruno R, Campbell G, Mattick RP, Larance B, Hall W.

Drug Alcohol Rev. 2013 Sep;32(5):468-74. doi: 10.1111/dar.12066. Epub 2013 Jul 25.

PMID:
23889303
12.

A typology of people who tamper with pharmaceutical opioids: responses to introduction of a tamper-resistant formulation of controlled-release oxycodone.

Peacock A, Degenhardt L, Larance B, Cama E, Lintzeris N, Ali R, Bruno R.

Pharmacoepidemiol Drug Saf. 2015 Dec;24(12):1321-33. doi: 10.1002/pds.3883. Epub 2015 Sep 30.

PMID:
26419615
13.

Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.

Winstock AR, Lea T, Sheridan J.

Int J Drug Policy. 2008 Dec;19(6):450-8. doi: 10.1016/j.drugpo.2007.03.002. Epub 2008 Mar 21.

PMID:
18359216
14.

Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics.

Coplan PM, Kale H, Sandstrom L, Landau C, Chilcoat HD.

Pharmacoepidemiol Drug Saf. 2013 Dec;22(12):1274-82. doi: 10.1002/pds.3522. Epub 2013 Sep 30.

15.

Type of opioids injected: does it matter? A multicentric cross-sectional study of people who inject drugs.

Ambekar A, Rao R, Mishra AK, Agrawal A.

Drug Alcohol Rev. 2015 Jan;34(1):97-104. doi: 10.1111/dar.12208. Epub 2014 Oct 10.

PMID:
25302827
16.

Changing patterns in opioid addiction: characterizing users of oxycodone and other opioids.

Sproule B, Brands B, Li S, Catz-Biro L.

Can Fam Physician. 2009 Jan;55(1):68-9, 69.e1-5.

17.

Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia.

Humeniuk R, Ali R, McGregor C, Darke S.

Addiction. 2003 Apr;98(4):413-8.

PMID:
12653811
18.

Heroin transition risk among daily and non-daily cannabis users who are non-injectors of heroin.

Valdez A, Cepeda A, Neaigus A, Russell A.

Int J Drug Policy. 2008 Dec;19(6):442-9. doi: 10.1016/j.drugpo.2007.06.004. Epub 2007 Aug 6.

19.

The characteristics of a cohort who tamper with prescribed and diverted opioid medications.

Larance B, Lintzeris N, Bruno R, Peacock A, Cama E, Ali R, Kihas I, Hordern A, White N, Degenhardt L.

J Subst Abuse Treat. 2015 Nov;58:51-61. doi: 10.1016/j.jsat.2015.06.001. Epub 2015 Jun 24.

PMID:
26286818
20.

Intravenous oxycodone, hydrocodone, and morphine in recreational opioid users: abuse potential and relative potencies.

Stoops WW, Hatton KW, Lofwall MR, Nuzzo PA, Walsh SL.

Psychopharmacology (Berl). 2010 Oct;212(2):193-203. doi: 10.1007/s00213-010-1942-4. Epub 2010 Jul 28.

Supplemental Content

Support Center